ID: ALA4875474

Max Phase: Preclinical

Molecular Formula: C39H51N4O7PS

Molecular Weight: 750.90

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)OC(=O)[C@H](Cc1ccccc1)NP(=O)(COCCc1nc(N)sc1-c1cccc(OC(C)C)c1)N[C@@H](Cc1ccccc1)C(=O)OC(C)C

Standard InChI:  InChI=1S/C39H51N4O7PS/c1-26(2)48-32-19-13-18-31(24-32)36-33(41-39(40)52-36)20-21-47-25-51(46,42-34(37(44)49-27(3)4)22-29-14-9-7-10-15-29)43-35(38(45)50-28(5)6)23-30-16-11-8-12-17-30/h7-19,24,26-28,34-35H,20-23,25H2,1-6H3,(H2,40,41)(H2,42,43,46)/t34-,35-/m0/s1

Standard InChI Key:  VTLGKKGJLAWRMY-PXLJZGITSA-N

Associated Targets(Human)

Brain adenylate cyclase 1 372 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenylate cyclase type II 148 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenylate cyclase type III 24 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

J774.A1 2436 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 750.90Molecular Weight (Monoisotopic): 750.3216AlogP: 7.19#Rotatable Bonds: 20
Polar Surface Area: 151.10Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.60CX Basic pKa: 4.56CX LogP: 6.54CX LogD: 6.54
Aromatic Rings: 4Heavy Atoms: 52QED Weighted: 0.05Np Likeness Score: -0.43

References

1. Břehová P, Chaloupecká E, Česnek M, Skácel J, Dračínský M, Tloušťová E, Mertlíková-Kaiserová H, Soto-Velasquez MP, Watts VJ, Janeba Z..  (2021)  Acyclic nucleoside phosphonates with 2-aminothiazole base as inhibitors of bacterial and mammalian adenylate cyclases.,  222  [PMID:34102377] [10.1016/j.ejmech.2021.113581]

Source